Trial Profile
Effectiveness of Testosterone Replacement Therapy (TRT) on Prostatic Gland in Hypogonadal Patients Affected by Benign Prostatic Hyperplasia (BPH) and Metabolic Syndrome (MetS). Florence-PROTEST
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2022
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism; Lower urinary tract symptoms
- Focus Therapeutic Use
- Acronyms Florence-PROTEST; PROTEST
- 17 Mar 2022 Results published in the Journal of Endocrinological Investigation
- 25 Oct 2017 Status changed from active, no longer recruiting to completed.
- 24 Oct 2016 Planned number of patients changed from 120 to 144.